✦ LIBER ✦

Effect of fluticasone propionate/salmeterol (250/50 μg) or salmeterol (50 μg) on COPD exacerbations

✍ Scribed by Gary T. Ferguson; Antonio Anzueto; Richard Fei; Amanda Emmett; Katharine Knobil; Christopher Kalberg

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of fluticasone propio

✍ Stephanie R. Earnshaw; Michele R. Wilson; Anand A. Dalal; Mike G. Chambers; Prit 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 295 KB

Initiation of maintenance treatment with

✍ N.C. Barnes; L. Jacques; C. Goldfrad; E.D. Bateman 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 342 KB

Efficacy and safety of fluticasone propi

✍ Edward M. Kerwin; Robert A. Nathan; Eli O. Meltzer; Hector G. Ortega; Steven W. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 307 KB

Role of add-on zileuton on total exhaled

✍ Arthur F. Gelb; Colleen Flynn Taylor; Michael Simmons; Chris Shinar 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 270 KB

Steroid-sparing effects of fluticasone p

✍ Busse, William; Koenig, Steven M.; Oppenheimer, John; Sahn, Steven A.; Yancey, S 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 290 KB

Salmeterol & Fluticasone 50 μg/250 μg bi

✍ Roberto Walter Dal Negro; Carlo Pomari; Silvia Tognella; Claudio Micheletto 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Effect of fluticasone propionate/salmeterol (250/50&#xa0;μg) or salmeterol (50&#xa0;μg) on COPD exacerbations